Skip to content
Screener

CeriBell, Inc. CBLL Total Liabilities & Equity

Total Liabilities & Equity at other companies

IAR
Integra LifeSciencesIART
$3.56B-2.8%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$93.42M+211%
iRadimed logo
iRadimedIRMD
$114.39M+12.4%
Teladoc Health logo
Teladoc HealthTDOC
$2.76B-4.7%
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
$1.09B+13.4%
ICU Medical logo
ICU MedicalICUI
$3.97B-3.3%

Other financials

Income statement

See full
Revenue$28.1M+32.5%
Gross profit$25.9M+38.8%
Operating income-$20.0M-33.6%
Net income-$19.3M-41.2%
EPS (diluted)-$0.51-34.2%

Balance sheet

See full
Cash & equivalents$32.7M-18.6%
Total debt$21.9M+1.7%
Total equity$128.3M-25.5%
Total assets$166.3M-19.9%

Cash flow

See full
Operating cash flow-$12.9M-70.8%
CapEx$17.0K-76.1%
Free cash flow-$12.9M-69.4%

Valuation

See full
Market cap$713.7M+50.8%
Enterprise value$702.95M+54.6%
P/S+0.9×

Profitability

See full
Gross margin88.9%+1.1pp
Operating margin-68.6%+1.5pp
Net margin-64.7%+0.9pp
FCF margin-53.7%+4.4pp

Returns & leverage

See full
Return on equity-43.9%
Debt / equity0.2×0.0×
Current ratio9.2×-4.1×

Where this comes from

Reported directly by CeriBell, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: CeriBell, Inc.’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:50 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-342574
Line itemJune 30, 2026December 31, 2025
Common stock, $0.001 par value;
Authorized shares: 500,000,000 as of June 30, 2026 and December 31, 2025, respectively
Issued and outstanding shares: 38,223,221 and 37,485,124 as of June 30, 2026 and December 31, 2025, respectively3938
Additional paid-in capital387,727375,495
Accumulated other comprehensive income (loss)(92)159
Accumulated deficit(259,361)(220,356)
Total stockholders’ equity128,313155,336
Total liabilities and stockholders’ equity$166,348$195,803

Item 1. Financial Statements.

FAQ

What is CeriBell, Inc.'s total liabilities & equity?
CeriBell, Inc. (CBLL) reported total liabilities & equity of $166.35M in Q2 2026.
How has CeriBell, Inc.'s total liabilities & equity changed year-over-year?
CeriBell, Inc.'s total liabilities & equity decreased by 19.9% year-over-year, from $207.69M to $166.35M.
What is the long-term trend for CeriBell, Inc.'s total liabilities & equity?
Over 2 years (2023 to 2025), CeriBell, Inc.'s total liabilities & equity has grown at a 82.3% compound annual growth rate (CAGR), from $58.92M to $195.8M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about CeriBell, Inc.'s total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude